Log inSign up
Pharma-Marketing.comPharma-Marketing.com
  • Industry
  • Digital Health & AI
  • Channels
  • People
  • Agencies
  • Glossary
Log inSign up
  • Terms of Service
  • Privacy Policy
  • Cookie settings
  • Imprint
Pharma-Marketing.com


All rights reserved.

We use AI tools in the creation of certain content.

Pharma Marketing

Data-privacy settings

We use cookies to improve our website and services. They help us understand how visitors use our website. Some cookies are required for the website to function. These are marked as “essential” in the details.

AcceptEssential cookie
NameData-privacy settings
ProviderPharma-Marketing.com
PurposeStores these privacy settings in your browser.
Privacy policyPrivacy policy
Cookiespm_data_privacy
Cookie expiration180 days
Accept
NameGoogle Analytics
ProviderGoogle LLC
PurposeCookies by Google are used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_ga, _gat, _gid
Cookie expiration2 Years
Accept
NameGoogle Ads
ProviderGoogle LLC
PurposeCookies by Google Ads are used for advertising and targeting purpose.
Privacy policyPrivacy policy
Cookies__gsas, __gpi, __gpi_optout, NID, DSID, test_cookie, id, __gads
Cookie expiration2 Years
Accept
NameFacebook
ProviderFacebook Inc.
PurposeCookies by Facebook are used for advertising and marketing activities. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_fbp, fr
Cookie expiration2 Years
Accept
NameMicrosoft Clarity
ProviderMicrosoft Corporation
PurposeCookies by Microsoft Clarity are used for website analytics, heatmaps, and session recordings. They help us understand how visitors interact with our website so we can improve usability and performance.
Privacy policyPrivacy policy
Cookies_clck, _clsk, CLID, ANONCHK, MR, MUID, SM
Cookie expirationUp to 1 Year
© Image: Hims&Hers

Monday, March 23, 2026

Hims & Hers shifts US weight loss strategy with Novo Nordisk deal

Hims & Hers Health has announced a strategic shift in its US weight loss business. The company said it is aligning its domestic approach more closely with its international model, starting with a collaboration with Novo Nordisk.

Emphasis on FDA-approved GLP-1 medicines

According to the company, US customers seeking GLP-1-based weight loss care are expected to get access to a broader range of FDA-approved medications. Hims & Hers also said it intends to continue offering compounded semaglutide only on a limited basis, where a provider determines a compounded product is clinically necessary.

As part of the change, the company said it will stop advertising compounded GLP-1 offerings on its platform and in marketing. Existing patients are expected to have an option to transition to FDA-approved medicines when providers consider it clinically appropriate.

Ozempic and Wegovy planned for the platform

Hims & Hers said its agreement with Novo Nordisk will bring Ozempic (semaglutide) injections in 0.5 mg, 1 mg, and 2 mg, as well as Wegovy (semaglutide) pills and injections, to the platform later this month. The company listed Wegovy injections at 1.7 mg and 2.4 mg and Wegovy tablets at 1.5 mg, 4 mg, 9 mg, and 25 mg.

Over the coming months, Hims & Hers said it will inform US weight loss customers about the expanded set of FDA-approved options and support transitions where clinicians deem it appropriate. The companies also indicated they may work together on additional products as they become available.

Support services and litigation update

Hims & Hers said it will continue to provide support services alongside treatment, including access to providers, nutrition guidance, and ongoing clinical check-ins.

At the same time, the company said Novo Nordisk is dismissing its lawsuit against Hims & Hers without prejudice.

More information is available via the company’s newsroom at news.hims.com.

Advertisement

Only a few physicians log in to your website?

Advertisement

A login that sets a new standard for authenticating HCPs and equips your marketing team with everything they need to successfully promote Rx-products. Learn more on DocID.pro


Stay up to date!

Subscribe to our free Pharma-Marketing-Newsletter.


A Partner For Successful Marketing in Pharma & Healthcare

Advertisement

8awake, the specialized agency for pharma and healthcare marketing, supports you with the successful development and execution of winning campaign activities in healthcare.

Leading providers in pharma and healthcare marketing

Sponsored
  • MINTT Digital
  • 8awake
  • MINTT Digital

  • 8awake

    The leading Healthcare & Pharma-Marketing-Agency

Looking for a new partner in pharma and healthcare marketing?

Visit our agency finder

Copyright 2026 Pharma-Marketing.com.